Colonic stenting or surgery in left-sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial
ISRCTN | ISRCTN01790428 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN01790428 |
Secondary identifying numbers | 1206 |
- Submission date
- 20/12/2005
- Registration date
- 20/12/2005
- Last edited
- 15/07/2021
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Jeanin van Hooft
Scientific
Scientific
Afd. Maag-, Darm- en Leverziekten, C2-220
Academisch Medisch Centrum
P.O. Box 22660
Amsterdam
1105 AZ
Netherlands
Phone | +31 (0)63 002 3579 |
---|---|
info@stent-in.nl |
Study information
Study design | Multicentre, randomised, active controlled, parallel group trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Colonic stenting or surgery in left-sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial |
Study acronym | Stent-in I study |
Study objectives | 1. Patients with incurable disseminated left-sided colonic cancer are better palliated by colonic stenting than surgery, measured by hospital free survival in "good health" (World Health Organization [WHO] score 0 or 1) 2. Colonic stenting is cost effective in patients with incurable disseminated left-sided colonic cancer |
Ethics approval(s) | Ethics approval received from the local medical ethics committee |
Health condition(s) or problem(s) studied | Colonic cancer |
Intervention | Surgical palliation versus "wait and see" policy and colonic stenting if obstruction is imminent. |
Intervention type | Other |
Primary outcome measure | 1. Total hospital free survival in good health (corrected for days with a WHO performance status greater than 1) 2. Integral costs (product of volume consumed care and prices of means (personnel, overhead, material and investments) |
Secondary outcome measures | 1. Procedural related hospital stay and mortality and morbidity 2. Efficacy of palliation of (imminent) obstruction (complaints, secondary operation or stent placement) 3. Quality of life |
Overall study start date | 01/12/2004 |
Completion date | 01/01/2008 |
Reason abandoned (if study stopped) | Objectives no longer viable |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 180 |
Total final enrolment | 21 |
Key inclusion criteria | 1. Left sided colonic cancer (from left flexure to greater than 10 cm of anus) 2. Diagnosis histological proven 3. No signs of double tumour 4. Informed consent |
Key exclusion criteria | 1. Potentially curable disease 2. American Society of Anaesthesiologists (ASA) IV or V 3. Ileus 4. Karnofsky index of less than 50% |
Date of first enrolment | 01/12/2004 |
Date of final enrolment | 01/01/2008 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Afd. Maag-, Darm- en Leverziekten, C2-220
Amsterdam
1105 AZ
Netherlands
1105 AZ
Netherlands
Sponsor information
Academic Medical Centre (AMC) (Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Department of Obstetrics and Gynaecology
Meibergdreef 9
Amsterdam
1105 AZ
Netherlands
Website | http://www.amc.uva.nl/ |
---|---|
https://ror.org/03t4gr691 |
Funders
Funder type
Research organisation
The Netherlands Organization for Health Research and Development (ZonMw) (The Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | premature closure results | 04/11/2006 | 15/07/2021 | Yes | No |
Editorial Notes
15/07/2021: The trial was stopped due to a high number of serious adverse events. Publication reference and total final enrolment added.